Rabbia Siddiqi
Overview
Explore the profile of Rabbia Siddiqi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Shah S, Mushahid H, Salman A, Farhan S, Latif F, Siddiqi R, et al.
Drugs Aging
. 2025 Feb;
42(3):195-211.
PMID: 39987306
Background: Recent guidelines recommend the use of sodium-glucose cotransporter 2 (SGLT-2) inhibitors (SGLT2i) in patients suffering from cardiorenal diseases. However, the safety and efficacy of SGLT2i in older adults with...
2.
Siddiqi R, Fares A, Mahmoud M, Asghar K, Assaly R, Eltahawy E, et al.
Indian Pacing Electrophysiol J
. 2024 Sep;
24(6):321-329.
PMID: 39270779
Patients with concurrent heart failure (HF) and atrial fibrillation (AF) have poor outcomes. Randomized clinical trials comparing rhythm control approaches to rate control of AF have yielded conflicting results and...
3.
Moiz Nasir M, Ikram A, Usman M, Sarwar J, Ahmed J, Hamza M, et al.
Am J Cardiol
. 2024 May;
225:151-159.
PMID: 38723857
Aortic stenosis is a common and significant valve condition requiring bioprosthetic heart valves with transcatheter aortic valve replacement (TAVR) being strongly recommended for high-risk patients or patients over 75 years....
4.
Alharbi A, Shah M, Gupta M, Rejent K, Mahmoud M, Alsughayer A, et al.
Auton Neurosci
. 2024 Jan;
251:103144.
PMID: 38181551
Background: Vasovagal syncope (VVS) is a prevalent condition characterized by a sudden drop in blood pressure and heart rate, leading to a brief loss of consciousness and postural control. Recurrent...
5.
Riaz I, Naqvi S, He H, Asghar N, Siddiqi R, Liu H, et al.
JAMA Oncol
. 2023 Mar;
9(5):635-645.
PMID: 36862387
Importance: The effectiveness of triplet therapy compared with androgen pathway inhibitor (API) doublets in a heterogeneous patient population with metastatic castration-sensitive prostate cancer (mCSPC) is unknown. Objective: To assess the...
6.
Sonbol M, Siddiqi R, Uson P, Pathak S, Firwana B, Botrus G, et al.
Oncologist
. 2022 Oct;
27(12):1034-1040.
PMID: 36239399
Background: Despite multiple randomized trials, the role of perioperative chemotherapy in colorectal cancer liver metastasis (CRLM) is still under debate. In this systematic review and network meta-analysis (NMA), we aim...
7.
Riaz I, Sipra Q, Naqvi S, He H, Siddiqi R, Islam M, et al.
Crit Rev Oncol Hematol
. 2022 May;
175:103706.
PMID: 35537621
Objective: To assess comparative effectiveness of adjuvant therapies for renal cell carcinoma and quantify the absolute benefit of adjuvant treatments by clinicopathological risk groups. Methods: This 'living' review was conducted...
8.
Riaz I, Islam M, Khan A, Naqvi S, Siddiqi R, Rubab Khakwani K, et al.
Am J Med
. 2022 Apr;
135(8):984-992.e6.
PMID: 35483426
Purpose: We aim to describe reporting and representation of minority patient populations in immune checkpoint inhibitor (ICI) clinical trials and assess predictors of enrollment disparity. Methods: Trial-level data were acquired...
9.
Chakraborty R, Siddiqi R, Willson G, Gupta S, Asghar N, Husnain M, et al.
Cancer
. 2022 Apr;
128(12):2288-2297.
PMID: 35377484
Background: Despite routine evaluation of cytogenetics in myeloma, little is known regarding the impact of high-dose therapy (HDT) consolidation on overall survival (OS) or progression-free survival (PFS) in patients who...
10.
Riaz I, Siddiqi R, Islam M, He H, Riaz A, Asghar N, et al.
JCO Clin Cancer Inform
. 2021 May;
5:588-599.
PMID: 34043431
Purpose: Multiple large clinical trials have investigated adjuvant tyrosine kinase inhibitors (TKIs) to reduce the risk of cancer recurrence and progression to metastasis in high-risk renal cell carcinoma. We sought...